The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors

Artaç, Mehmet; Bozcuk, Hakan; Afacan, Berna; Özdoğan, Mustafa; Samur, Mustafa

doi:10.1016/j.breast.2008.01.007

Cited by 7 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However strategies to modify these behaviors are likely to influence the long-term pattern of weight change. 9,[30][31][32][33][34][35] In the results for the linear regression of mixed effects the women exposed to chemotherapy or chemotherapy combined with radiotherapy exhibited mean increases in body weight of 2.47 kg and 5.21 kg, respectively. This finding is in agreement with the observations of other authors who have verified an increase in body weight associated with adjuvant therapies for breast cancer.…”

Section: Discussionmentioning

confidence: 99%

Effect of adjuvant antineoplastic treatment on body weight change in women with breast cancer

Ambrosi

Pietro

Vieira

et al. 2012

Sci Med

View full text Add to dashboard Cite

AIMS: To identify the effect of adjuvant antineoplastic treatment on body weight change of women with breast cancer. METHODS: A non-randomized clinical study included women with a recent surgical diagnosis of breast cancer, admitted to the Maternidade Carmela Dutra hospital in Florianópolis, Santa Catarina, southern Brazil, between October 2006 and July 2008. Food intake, weight, body mass index, hip circumference, waist circumference and other variables were measured before (baseline) and after the adjuvant antineoplastic treatment (pos-treatment). A mixed effects linear regression model was used to estimate the longitudinal changes occurring in weight. RESULTS: The sample comprised 53 patients. A significant increase (P less than 0.05) was observed in body weight (2.81 kg), body mass index (1.08 kg/m2), hip circumference (3.62 cm) and waist circumference (1.93 cm). In relation to diet, there was a significant increase (P less than 0.05) in the intake of energy (272.7 kcal), total fat (11.2 g) and polyunsaturated fatty acids (5.4 g). The final regression model for the change in body weight demonstrated that the women who were exposed to chemotherapy treatment, and to chemotherapy associated with radiotherapy, had the largest mean increase in body weight (2.47 kg and 5.21 kg, respectively). Socio-economic, demographic and nutritional factors were not associated with the increase in body weight. CONCLUSIONS: Weight gain was associated with chemotherapy treatment either alone or in combination with radiotherapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of adjuvant antineoplastic treatment on body weight change in women with breast cancer

Ambrosi

Pietro

Vieira

et al. 2012

Sci Med

View full text Add to dashboard Cite

show abstract

Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis

Chan

Vieira

Abar

et al. 2022

Intl Journal of Cancer

View full text Add to dashboard Cite

Previous evidence on postdiagnosis body fatness and mortality after breast cancer was graded as limited-suggestive. To evaluate the evidence on body mass index (BMI), waist circumference, waist-hip-ratio and weight change in relation to breast cancer prognosis, an updated systematic review was conducted. PubMed and Embase were searched for relevant studies published up to 31 October, 2021. Random-effects meta-analyses were conducted to estimate summary relative risks (RRs).The evidence was judged by an independent Expert Panel using pre-defined grading criteria. One randomized controlled trial and 225 observational studies were reviewed (220 publications). There was strong evidence (likelihood of causality: probable) that higher postdiagnosis BMI was associated with increased all-cause mortality (64 studies, 32 507 deaths), breast cancer-specific mortality (39 studies, 14 106 deaths) and second primary breast cancer (11 studies, 5248 events). The respective summary RRs and 95% confidence intervals per 5 kg/m 2 BMI were 1.

show abstract

The Importance of Controlling Body Weight After a Diagnosis of Breast Cancer: The Role of Diet and Exercise in Breast Cancer Patient Management

Harvie¹

2009

Exercise and Cancer Survivorship

View full text Add to dashboard Cite

The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors

Cited by 7 publications

References 18 publications

Effect of adjuvant antineoplastic treatment on body weight change in women with breast cancer

Effect of adjuvant antineoplastic treatment on body weight change in women with breast cancer

Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis

The Importance of Controlling Body Weight After a Diagnosis of Breast Cancer: The Role of Diet and Exercise in Breast Cancer Patient Management

Contact Info

Product

Resources

About